Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Cancers
|
May 14, 2022
P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhiitor Ensartinib in Cancer Cells
Chung-Pu Wu, Cheng-Yu Hung, Megumi Murakami, et al.
Cancers
|
May 30, 2020
Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
Chung-Pu Wu, Tai-Ho Hung, Sung-Han Hsiao, et al.
Cells
|
April 13, 2023
ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines
Chung-Pu Wu, Cheng-Yu Hung, Ya-Ju Hsieh, et al.
International Journal of Molecular Sciences
|
September 28, 2023
Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells
Chung-Pu Wu, Yen-Ching Li, Megumi Murakami, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 9, 2026
Attenuation of ABCG2-dependent drug efflux by befotertinib restores chemosensitivity in multidrug-resistant non-small cell lung cancer cells
Yen-Ching Li, Ting-Yu Chen, Hui-Chiau Chuang, et al.
Molecules (Basel, Switzerland)
|
March 24, 2018
Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes
Yuan Quan, Meng-Yuan Liu, Ye-Mao Liu, et al.
Biochemical Pharmacology
|
July 21, 2018
Human ATP-binding cassette transporters ABCB1 and ABCG2 confer resistance to histone deacetylase 6 inhibitor ricolinostat (ACY-1215) in cancer cell lines
Chung-Pu Wu, Ya-Ju Hsieh, Megumi Murakami, et al.
Molecular Pharmaceutics
|
January 23, 2016
Human ATP-Binding Cassette Transporter ABCG2 Confers Resistance to CUDC-907, a Dual Inhibitor of Histone Deacetylase and Phosphatidylinositol 3-Kinase
Chung-Pu Wu, Ya-Ju Hsieh, Sung-Han Hsiao, et al.
Cell Transplantation
|
February 15, 2017
Treatment of Spinocerebellar Ataxia With Mesenchymal Stem Cells: A Phase I/IIa Clinical Study
Yun-An Tsai, Ren-Shyan Liu, Jiing-Feng Lirng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 4, 2007
Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes
Hsien-Tsung Yao, Yu-Shan Wu, Yi-Wei Chang, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Cancers
|
May 14, 2022
P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhiitor Ensartinib in Cancer Cells
Chung-Pu Wu, Cheng-Yu Hung, Megumi Murakami, et al.
Cancers
|
May 30, 2020
Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
Chung-Pu Wu, Tai-Ho Hung, Sung-Han Hsiao, et al.
Cells
|
April 13, 2023
ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines
Chung-Pu Wu, Cheng-Yu Hung, Ya-Ju Hsieh, et al.
International Journal of Molecular Sciences
|
September 28, 2023
Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells
Chung-Pu Wu, Yen-Ching Li, Megumi Murakami, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 9, 2026
Attenuation of ABCG2-dependent drug efflux by befotertinib restores chemosensitivity in multidrug-resistant non-small cell lung cancer cells
Yen-Ching Li, Ting-Yu Chen, Hui-Chiau Chuang, et al.
Molecules (Basel, Switzerland)
|
March 24, 2018
Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes
Yuan Quan, Meng-Yuan Liu, Ye-Mao Liu, et al.
Biochemical Pharmacology
|
July 21, 2018
Human ATP-binding cassette transporters ABCB1 and ABCG2 confer resistance to histone deacetylase 6 inhibitor ricolinostat (ACY-1215) in cancer cell lines
Chung-Pu Wu, Ya-Ju Hsieh, Megumi Murakami, et al.
Molecular Pharmaceutics
|
January 23, 2016
Human ATP-Binding Cassette Transporter ABCG2 Confers Resistance to CUDC-907, a Dual Inhibitor of Histone Deacetylase and Phosphatidylinositol 3-Kinase
Chung-Pu Wu, Ya-Ju Hsieh, Sung-Han Hsiao, et al.
Cell Transplantation
|
February 15, 2017
Treatment of Spinocerebellar Ataxia With Mesenchymal Stem Cells: A Phase I/IIa Clinical Study
Yun-An Tsai, Ren-Shyan Liu, Jiing-Feng Lirng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 4, 2007
Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes
Hsien-Tsung Yao, Yu-Shan Wu, Yi-Wei Chang, et al.
Page
of 6